BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Diagnosis
75 results:

  • 1. [Acute myeloid leukemia with type I cbfb::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
    Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
    Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
    Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
    J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 4. Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.
    Vundinti BR; Korgaonkar S; Dhangar S; Jijina F; Shanmukhaiah C
    J Cancer Res Ther; 2023; 19(2):340-346. PubMed ID: 37006070
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases.
    Chen Y; Wang Q; Cen J; Xu C; Tao TT; Xie J; Shen W; Gong Y; Pan J; Yao L
    Mol Carcinog; 2023 Feb; 62(2):117-121. PubMed ID: 36321418
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia].
    Yamamoto R; Suyama T; Yoshizawa Y; Shimizu M; Kuroda A; Shinagawa A
    Rinsho Ketsueki; 2022; 63(8):860-864. PubMed ID: 36058855
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Acute hepatitis-like presentation with cholestasis of cbfb-MYH11-positive acute myeloid leukemia in an adult male: a case report.
    Spinelli I; De Santis A; Cesini L; Riminucci M; Corsi A; Forlino M; Perrone EP; Minotti C; Cartoni C
    J Med Case Rep; 2022 Jul; 16(1):294. PubMed ID: 35907896
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/cbfb-MYH11 acute myeloid leukemia.
    Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
    Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 3'cbfb deletion in cbfb-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant.
    Tang G; Zou Y; Wang SA; Borthakur G; Toruner G; Hu S; Li S; Xu J; Medeiros LJ; Tang Z
    Ann Hematol; 2022 Apr; 101(4):847-854. PubMed ID: 35184217
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nilotinib-induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-Chronic Myeloid leukemia: Final report of the PhilosoPhi34 study.
    Pungolino E; D'adda M; De Canal G; Trojani A; Perego A; Elena C; Lunghi F; Turrini M; Borin L; Iurlo A; Latargia ML; Carraro MC; Spina F; Artale S; Anghilieri M; Molteni A; Caramella M; Baruzzo G; Nichelatti M; Di Camillo B; Cairoli R
    Eur J Haematol; 2021 Oct; 107(4):436-448. PubMed ID: 34139044
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidental identification of inv(16)(p13.1q22)/
    Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia.
    Kim T; Moon JH; Ahn JS; Ahn SY; Jung SH; Yang DH; Lee JJ; Shin MG; Choi SH; Lee JY; Tyndel MS; Lee HY; Kim KH; Cai Y; Lee YJ; Sohn SK; Min YH; Cheong JW; Kim HJ; Zhang Z; Kim DDH
    Sci Rep; 2020 Nov; 10(1):20119. PubMed ID: 33208771
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Driver Mutations in Acute Myeloid leukemia with Inversion of Chromosome 16].
    Ghukasyan LG; Krasnov GS; Muravenko OV; Ikonnikova AY; Yurasov RA; Baidun LV; Ibragimova SZ; Nasedkina TV
    Mol Biol (Mosk); 2020; 54(3):389-397. PubMed ID: 32492002
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
    Kabadi SM; Goyal RK; Nagar SP; Kaye JA; Davis KL
    Cancer Med; 2019 Jul; 8(8):3803-3810. PubMed ID: 31144473
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in
    Park SH; You E; Park CJ; Jang S; Cho YU; Yoon CH; Koh KN; Im HJ; Seo JJ
    Ann Lab Med; 2019 Jul; 39(4):358-366. PubMed ID: 30809981
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Synchronous diagnosis of
    Shoyele O; Gupta G
    Ann Clin Lab Sci; 2018 Nov; 48(6):790-796. PubMed ID: 30610052
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
    Zappasodi P; Marbello L; Borlenghi E; Fumagalli M; Bernardi M; Fracchiolla N; Mancini V; Da ViĆ  M; Ravano E; Cerqui E; Ferretti VV; Rocca B; Calvello C; Cazzola M; Castagnola C; Rossi G
    Ann Hematol; 2018 Nov; 97(11):2107-2115. PubMed ID: 30009341
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Acute Myeloid leukemia: diagnosis and Management Based on Current Molecular Genetics Approach.
    Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
    Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
    Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Autonomous feedback loop of RUNX1-p53-cbfb in acute myeloid leukemia cells.
    Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
    Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.